<DOC>
	<DOCNO>NCT01420575</DOCNO>
	<brief_summary>We hypothesize use visual decision aid tool educate patient regard potential harm respect weight gain olanzapine versus perphenazine lead well share decision make patient , increase rate antipsychotic switch promote weight loss overweight patient schizophrenia/schizoaffective disorder . Our specific aim follow : 1 . To investigate effect visual decision aid , versus care usual , patient ' perceive difficulty medical decision make regard switch antipsychotic overweight veteran schizophrenia schizoaffective disorder . 2 . To investigate effect visual decision aid share decision make model rate medication switch ( olanzapine perphenazine ) overweight veteran schizophrenia schizoaffective disorder . 3 . To investigate effect visual decision making aid share decision make model BMI overweight veteran switch olanzapine perphenazine therapy .</brief_summary>
	<brief_title>Decision Aid Facilitate Shared Decision Making During Treatment Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Perphenazine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Patients diagnosis Schizophrenia Schizoaffective Disorder per medical record diagnosis . Patients currently olanzapine therapy BMI &gt; 29.9 . Patients treat olanzapine great equal 3 month prior enrollment . Patient would require either attempted dietary , lifestyles modification and/or participate weight loss program . Patients history psychiatric hospitalization past six month judge treat clinician suitable antipsychotic medication switch . Patients adequate decisional capacity make choice participate research study . Patients , able comprehend satisfactorily comply protocol requirement ability read write English . Patients , sign write consent give prior enter study procedure . Patients history treatment resistant schizophrenia past trial clozapine . Patients concurrent DSMIV diagnosis PTSD per medical record . Substance Dependence Abuse ( exclude nicotine ) within one month prior screen visit . Patients history nonresponse , intolerance hypersensitivity ot perphenazine . Subjects history treatment clozapine . Patients base history mental status examination significant risk commit suicide . Patients homicidal violent Investigator 's opinion significant imminent risk hurt others . Female patient pregnant , plan become pregnant , childbearing potential , use acceptable method birth control . Patient currently receive depot neuroleptic . Patients visual impairment .</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>Schizoaffective Disorder</keyword>
	<keyword>Shared Decision</keyword>
	<keyword>Decision Aid</keyword>
	<keyword>Antipsychotic</keyword>
	<keyword>Weight Gain</keyword>
	<keyword>Olanzapine</keyword>
	<keyword>Lexapro</keyword>
	<keyword>Perphenazine</keyword>
</DOC>